Retracted
Kuntai capsule attenuates premature ovarian failure through the PI3K/AKT/mTOR pathway
Bibliographic Data
| ID | 17637653 |
|---|---|
| Authors | Han Zhang (0000-0002-5265-7659, Nanjing University of Chinese Medicine), Fenfen Qin (0000-0003-4450-4721, Nanjing University of Chinese Medicine), Anlong Liu (0000-0001-8096-9759, Nanjing University of Chinese Medicine), Qinmei Sun (0000-0001-5934-5909, Nanjing University of Chinese Medicine), Qisheng Wang (0000-0002-0614-6903, Nanjing University of Chinese Medicine), Qian Li (0000-0003-1286-8539, Nanjing University of Chinese Medicine), Shengfeng Lu (0000-0002-9832-7719), Sheng-Feng Lu (0000-0001-5600-0999, Nanjing University of Chinese Medicine), Dong Zhang (0000-0003-3786-2272, Nanjing University), Zhigang Lu (0000-0001-6769-3647, Nanjing University of Chinese Medicine, corresponding author) |
| Year | 2019 |
| Volume | 239 |
| Pages | 111885-111885 |
| Publication date | 2019-04-19 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2019.111885 |
| PMID | 31009706 |
| OpenAlex | W2940072739 |
| Language | EN |
| Citations received | 4 |
| References cited | 29 |
Biology · PI3K/AKT/mTOR pathway · Premature ovarian failure · Protein kinase B · Signal transduction · Medicine · Ovarian cancer diagnosis and treatment · Ovarian function and disorders · Reproductive Biology and Fertility · Endocrinology · Genetics · Internal Medicine
Erxian decoction alleviates cisplatin-induced premature ovarian failure in rats by reducing oxidation levels in ovarian granulosa cells
Danggui Shaoyao San protects cyclophosphamide-induced premature ovarian failure by inhibiting apoptosis and oxidative stress through the regulation of the Sirt1/p53 signaling pathway
Zihuai recipe alleviates cyclophosphamide-induced diminished ovarian reserve via suppressing PI3K/AKT-mediated apoptosis
Inhibition of p38 Mapk/NF-κB p65 signaling pathway activity by rare ginsenosides ameliorates cyclophosphamide-induced premature ovarian failure and KGN cell injury
| Citations per year | 0.8 |
|---|---|
| Citation span | 2021 - 2024 (4) |
| Highly cited | No |